Page last updated: 2024-09-04

conivaptan and Cardiac Failure

conivaptan has been researched along with Cardiac Failure in 58 studies

Research

Studies (58)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (3.45)	18.2507
2000's	35 (60.34)	29.6817
2010's	21 (36.21)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balling, L; Boesgaard, S; Goldsmith, SR; Gustafsson, F; Hassager, C; Thomsen, JH; Wolsk, E	1
Chibnall, JT; Godishala, A; Goff, ZD; Hauptman, PJ; Joseph, SM; Shuster, JE; Vidic, A	1
Iwao, H; Izumi, Y; Miura, K	1
Adams, KF; Lin, TE; Patterson, JH	1
Abrahams, Z; Chen, SY; Gonzalez-Stawinski, GV; Hobbs, R; Mullens, W; Sokos, GG; Taylor, DO	1
Farmakis, D; Filippatos, G; Gheorghiade, M; Kremastinos, DT	1
Boerrigter, G; Burnett, JC; Costello-Boerrigter, LC	1
Kumar, SK; Mather, PJ	1
Barve, A; Elkayam, U; Goldsmith, SR; Haught, WH; He, W	1
Filippatos, G; Parissis, JT	1
Elhassan, E; Masoumi, A; Schrier, RW	1
Afiniwala, M; Arumugham, P; Hoque, MZ; Huda, N; Karia, DH; Verma, N	1
Keirns, J; Mao, ZL; Stalker, D	1
Dhalla, NS; Rehsia, NS	1
Haass, M	1
Reilly, T; Schork, MR	1
Ghali, JK; Tam, SW	1
Hopkins, JP; Oliphant, CS; Pinner, NA	1
Komai, Y; Palaniyandi, SS; Sukumaran, V; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K; Yamaguchi, K	1
Singh, M; Slawsky, MT; Valania, G	1
Chiong, JR; Jao, GT	1
Cantillo, DS; Comín Colet, J; Robledo, GG	1
Villabona, C	1
Fürstner, C; Gheorghiade, M; Kolkhof, P; Mondritzki, T; Sabbah, HN; Schaefer, S; Schmeck, C; Siedentop, H; Truebel, H	1
Er, F; Fuhr, U; Gassanov, N; Nia, AM; Semmo, M; Semmo, N	1
Fujiwara, Y; Koshimizu, TA; Tanoue, A; Tsujimoto, G	1
Gilbertson, DT; Goldsmith, SR; Mackedanz, SA; Swan, SK	1
Burnett, JC; Costello-Boerrigter, LC	1
Alemayehu, A; O'Connell, JB	1
Dabrowska, MD; Krysiak, R; Okopień, B	1
Balaguru, D; Bricker, JT; Haque, I; Pham-Peyton, C; Sahu, R; Thapar, V	1
Cherubini, A; Di Lenarda, A; Perkan, A; Salvatore, L; Sinagra, G	1
Aoki, M; Arai, Y; Tahara, A; Tomura, Y; Tsukada, J; Wada, K; Yatsu, T	1
Coats, AJ; Ghazzi, MM; Massey, KD; Pressler, M; Pyne, DA; Russell, SD; Selaru, P; Serikoff, A	1
Ferguson, JW; Hayes, PC; Newby, DE; Therapondos, G	1
Thibonnier, M	1
Arai, Y; Fujimori, A; Matsukawa, U; Miyata, K; Sasamata, M; Sudoh, K; Wada, K; Yatsu, T	1
Doggrell, SA	1
Golestaneh, L; Le Jemtel, TH; Talreja, A	1
Sanghi, P; Schwarz, ER	1
Streefkerk, JO; van Zwieten, PA	1
Greenberg, A; Verbalis, JG	1
Omland, T; Solberg, OG	1
Ali, F; Ghali, JK; Guglin, M; Vaitkevicius, P	1
Walter, KA	1
Kumar, S; Mather, PJ; Rubin, S; Whellan, DJ	1
Głuszek, J; Olszewski, W	1
Hobbs, RE; Tang, WH	1
Schweiger, TA; Zdanowicz, MM	1
Honda, K; Iizumi, Y; Inagaki, O; Kusayama, T; Tahara, A; Tanaka, A; Tokioka, T; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T	1
Honda, K; Iizumi, Y; Kusayama, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Wada, K; Yatsu, T	1
Chanoine, F; Ghali, JK; Ghazzi, M; Hendrix, GH; Konstam, MA; Painchaud, CA; Pressler, ML; Selaru, P; Smith, WB; Thomas, I; Udelson, JE	1
Martinez-Castelao, A	1
Goldsmith, SR	1
Balding, LC; Burrell, LM; Johnston, CI; Naitoh, M; Risvanis, J	1

Reviews

35 review(s) available for conivaptan and Cardiac Failure

Article	Year
Therapeutic potential of vasopressin-receptor antagonists in heart failure. Journal of pharmacological sciences, 2014, Volume: 124, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling	2014
Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients. Heart failure clinics, 2014, Volume: 10, Issue:4 Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Heart Failure; Humans; Hyponatremia; Prospective Studies; Tolvaptan; Vasopressins	2014
Vasopressin and vasopressin antagonists in heart failure and hyponatremia. Current heart failure reports, 2008, Volume: 5, Issue:2 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Humans; Hyponatremia; Infusions, Intravenous; Male; Prognosis; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Risk Assessment; Survival Rate; Tolvaptan; Water-Electrolyte Imbalance	2008
Pharmacology of vasopressin antagonists. Heart failure reviews, 2009, Volume: 14, Issue:2 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Benzodiazepines; Heart Failure; Humans; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan	2009
AVP receptor antagonists in patients with CHF. Heart failure reviews, 2009, Volume: 14, Issue:2 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Sodium	2009
Role of vasopressin and vasopressin receptor antagonists in type I cardiorenal syndrome. Blood purification, 2009, Volume: 27, Issue:1 Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Failure; Humans; Hyponatremia; Kidney; Kidney Diseases; Vasopressins	2009
Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure. Heart failure reviews, 2010, Volume: 15, Issue:1 Topics: Angiotensin II; Animals; Antidiuretic Agents; Antihypertensive Agents; Benzazepines; Biomarkers; Bosentan; Catecholamines; Drug Therapy, Combination; Endothelin-1; Heart Failure; Humans; Peptides, Cyclic; Renin-Angiotensin System; Sulfonamides; Sympathetic Nervous System; Tolvaptan; Treatment Outcome; Vasopressins	2010
[Vasopressin receptor antagonists and heart failure]. Therapeutische Umschau. Revue therapeutique, 2009, Volume: 66, Issue:11 Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Female; Follow-Up Studies; Furosemide; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Indoles; Male; Morpholines; Platelet Aggregation Inhibitors; Pyrroles; Pyrrolidines; Sodium Potassium Chloride Symporter Inhibitors; Spiro Compounds; Time Factors; Tolvaptan	2009
Vasopressin antagonists: Pharmacotherapy for the treatment of heart failure. The Annals of pharmacotherapy, 2010, Volume: 44, Issue:4 Topics: Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Neurotransmitter Agents; Pyrroles; Tolvaptan; Vasopressins	2010
The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists. Journal of cardiac failure, 2010, Volume: 16, Issue:5 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Blood Pressure; Blood Volume; Female; Heart Failure; Humans; Hypertension; Hyponatremia; Male; Prevalence; Prognosis; Pyrroles; Receptors, Vasopressin; Tolvaptan; United States; Water-Electrolyte Balance	2010
Arginine vasopressin receptor antagonists (vaptans): pharmacological tools and potential therapeutic agents. Drug discovery today, 2010, Volume: 15, Issue:19-20 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Drug Evaluation, Preclinical; Heart Failure; Humans; Hyponatremia; Receptors, Vasopressin; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan	2010
Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists? Current heart failure reports, 2011, Volume: 8, Issue:3 Topics: Acute Disease; Animals; Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Hyponatremia; Prognosis; Pyrroles; Tolvaptan; Vasoconstriction; Vasopressins	2011
Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options. Clinical cardiology, 2010, Volume: 33, Issue:11 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Biomarkers; Fluid Therapy; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Receptors, Vasopressin; Renin-Angiotensin System; Sodium; Tolvaptan; Treatment Outcome; Ventricular Dysfunction	2010
[Hyponatremia in heart failure: physiopathology and pharmacological approach]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57 Suppl 2 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Brain Edema; Demyelinating Diseases; Diuresis; Diuretics; Double-Blind Method; Heart Failure; Humans; Hyponatremia; Kidney; Multicenter Studies as Topic; Natriuresis; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Renin-Angiotensin System; Saline Solution, Hypertonic; Sympathetic Nervous System; Tolvaptan	2010
[Vasopressin receptor antagonists: the vaptans]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57 Suppl 2 Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins	2010
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH). European journal of clinical pharmacology, 2011, Volume: 67, Issue:4 Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Biological; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan; Water-Electrolyte Balance	2011
The roles of V1a vasopressin receptors in blood pressure homeostasis: a review of studies on V1a receptor knockout mice. Clinical and experimental nephrology, 2012, Volume: 16, Issue:1 Topics: Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Blood Volume; Heart Failure; Homeostasis; Humans; Hyponatremia; Mice; Receptors, Vasopressin; Renin-Angiotensin System	2012
Hyponatremia, heart failure, and the role of tolvaptan. Postgraduate medicine, 2012, Volume: 124, Issue:2 Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diagnosis, Differential; Heart Failure; Humans; Hyponatremia; Prognosis; Tolvaptan; Treatment Outcome	2012
[Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2012, Volume: 65, Issue:1 Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Hyponatremia; Hypovolemia; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan	2012
[Treatment of heart failure: an update]. Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2002, Volume: 3, Issue:7 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antidiuretic Hormone Receptor Antagonists; Antihypertensive Agents; Benzazepines; Bosentan; Carbazoles; Carvedilol; Death, Sudden, Cardiac; Defibrillators, Implantable; Double-Blind Method; Heart Failure; Heart-Assist Devices; Humans; Metoprolol; Multicenter Studies as Topic; Placebos; Propanolamines; Prospective Studies; Pyridines; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tetrazoles; Valine; Valsartan; Vasodilator Agents	2002
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis. Clinical science (London, England : 1979), 2003, Volume: 105, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Diuretics; Heart Failure; Homeostasis; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Animal; Morpholines; Piperidines; Pyrroles; Quinolones; Rats; Spiro Compounds; Vasopressins	2003
Vasopressin receptor antagonists in heart failure. Current opinion in pharmacology, 2003, Volume: 3, Issue:6 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Pyrroles; Randomized Controlled Trials as Topic; Tolvaptan	2003
Conivaptan: YM 087. Drugs in R&D, 2004, Volume: 5, Issue:2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Diuretics; Dose-Response Relationship, Drug; Heart Failure; Humans; Metabolic Diseases; Randomized Controlled Trials as Topic; Rats	2004
Vasopressin antagonists in heart failure. Current heart failure reports, 2004, Volume: 1, Issue:4 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diuretics; Heart Failure; Humans; Randomized Controlled Trials as Topic; Tolvaptan; Water-Electrolyte Balance	2004
Conivaptan: a selective vasopressin antagonist for the treatment of heart failure. Expert review of cardiovascular therapy, 2006, Volume: 4, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Heart Failure; Humans; Receptors, Vasopressin	2006
Vasopressin receptor antagonists: pharmacological tools and potential therapeutic agents. Autonomic & autacoid pharmacology, 2006, Volume: 26, Issue:2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Drug Design; Heart Failure; Hormone Antagonists; Humans; Hypertension; Inappropriate ADH Syndrome; Indoles; Presynaptic Terminals; Pyrrolidines; Receptors, Vasopressin; Renal Artery; Sympathetic Nervous System; Synaptic Transmission; Tolvaptan; Vasoconstriction; Vasoconstrictor Agents	2006
Vasopressin receptor antagonists. Kidney international, 2006, Volume: 69, Issue:12 Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Clinical Trials as Topic; Diabetes Insipidus, Nephrogenic; Fibrosis; Heart Failure; Humans; Hyponatremia; Osmolar Concentration; Polycystic Kidney Diseases; Pyrroles; Receptors, Vasopressin; Sodium; Tolvaptan; United States; United States Food and Drug Administration; Vasopressins	2006
[Arginine vasopressin antagonism--new treatment option in chronic heart failure]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2007, Jan-18, Volume: 127, Issue:2 Topics: Animals; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Nephrons; Prognosis; Pyrroles; Receptors, Vasopressin; Tolvaptan; Treatment Outcome; Vasoconstrictor Agents	2007
Therapeutic potential of vasopressin receptor antagonists. Drugs, 2007, Volume: 67, Issue:6 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan	2007
Conivaptan: new treatment for hyponatremia. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Jul-01, Volume: 64, Issue:13 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Drug Costs; Drug Interactions; Heart Failure; Humans; Hyponatremia	2007
Hyponatremia and vasopressin antagonism in congestive heart failure. Clinical cardiology, 2007, Volume: 30, Issue:11 Topics: Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Chronic Disease; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Hyponatremia; Models, Biological; Pyrroles; Registries; Renin-Angiotensin System; Sodium; Tolvaptan; Treatment Outcome; Vasopressins	2007
[Vasopressin antagonists in treatment of hyponatremia]. Polskie Archiwum Medycyny Wewnetrznej, 2007, Volume: 117, Issue:8 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Sodium Chloride; Tolvaptan; Water-Electrolyte Balance	2007
Vasopressin receptor antagonists in heart failure. Recent patents on cardiovascular drug discovery, 2006, Volume: 1, Issue:2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Pyrroles; Receptors, Vasopressin; Tolvaptan; Vasopressins	2006
Vasopressin-receptor antagonists in heart failure. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, May-01, Volume: 65, Issue:9 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Cardiovascular Agents; Chronic Disease; Heart Failure; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan	2008
Conivaptan (Yamanouchi). Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:1 Topics: Animals; Benzazepines; Clinical Trials as Topic; Edema; Heart Failure; Humans; Hyponatremia; Technology, Pharmaceutical	2002

Trials

4 trial(s) available for conivaptan and Cardiac Failure

Article	Year
Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot study. Journal of cardiac failure, 2008, Volume: 14, Issue:8 Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; Benzazepines; Disease Progression; Diuresis; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Pain Measurement; Pilot Projects; Receptors, Vasopressin; Vasopressins	2008
Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure. Journal of cardiac failure, 2011, Volume: 17, Issue:12 Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Cross-Over Studies; Drug Therapy, Combination; Furosemide; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Kidney; Male; Middle Aged; Myocytes, Cardiac; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Time Factors; Ventricular Function, Left	2011
Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trial. American heart journal, 2003, Volume: 145, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Double-Blind Method; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Oxygen Consumption; Pulmonary Gas Exchange; Randomized Controlled Trials as Topic; Research Design	2003
Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure. Circulation, 2001, Nov-13, Volume: 104, Issue:20 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Double-Blind Method; Electrolytes; Female; Heart Failure; Hemodynamics; Humans; Kidney; Kinetics; Male; Middle Aged; Osmolar Concentration; Pulmonary Wedge Pressure; Urine	2001

Other Studies

19 other study(ies) available for conivaptan and Cardiac Failure

Article	Year
Hemodynamic effects of short-term infusion of a vasopressin V1A/V2 receptor antagonist conivaptan in patients withchronic heart failure during submaximal exercise. American heart journal, 2018, Volume: 203 Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Exercise Tolerance; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Randomized Controlled Trials as Topic; Stroke Volume; Time Factors; Ventricular Function, Left	2018
Vasopressin antagonism for decompensated right-sided heart failure. International journal of cardiology, 2019, Jan-01, Volume: 274 Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Creatinine; Diuresis; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Retrospective Studies; Stroke Volume; Tolvaptan; Treatment Outcome; Ventricular Function, Right	2019
Conivaptan: potential therapeutic implications in heart failure. Recent patents on cardiovascular drug discovery, 2008, Volume: 3, Issue:2 Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiovascular Agents; Diuretics; Heart Failure; Hormone Antagonists; Humans; Patents as Topic; Treatment Outcome; Water-Electrolyte Balance	2008
Vasopressin antagonists for the treatment of acute decompensated heart failure: when, for whom, for how long, and on what standard therapy? Journal of cardiac failure, 2008, Volume: 14, Issue:8 Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuresis; Heart Failure; Humans; Receptors, Vasopressin; Vasopressins	2008
Conivaptan: promise of treatment in heart failure. Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:13 Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Heart Failure; Humans; Hyponatremia; Receptors, Vasopressin	2009
Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study. Clinical therapeutics, 2009, Volume: 31, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; Benzazepines; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Half-Life; Heart Failure; Humans; Hyponatremia; Infusions, Intravenous; Male; Middle Aged; Young Adult	2009
Use of conivaptan for the treatment of symptomatic hyponatremia in a patient with acute decompensated heart failure. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Jun-15, Volume: 67, Issue:12 Topics: Aged; Benzazepines; Blood Urea Nitrogen; Cardiac Catheterization; Creatinine; Defibrillators, Implantable; Female; Heart Failure; Humans; Hyponatremia; Injections, Intravenous; Receptors, Vasopressin	2010
Differentiation of arginine vasopressin antagonistic effects by selective V2 versus dual V2/V1a receptor blockade in a preclinical heart failure model. American journal of therapeutics, 2011, Volume: 18, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Cardiac Output; Cardiac Pacing, Artificial; Dogs; Heart Failure; Hemodynamics; Pacemaker, Artificial; Tolvaptan; Urodynamics; Vascular Resistance	2011
Controlling the flood gates: vaptans, furosemide and the quest for a renal protective diuresis. Journal of cardiac failure, 2011, Volume: 17, Issue:12 Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Female; Furosemide; Heart Failure; Heart Failure, Systolic; Humans; Kidney; Male; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan	2011
Conivaptan therapy in an infant with severe hyponatremia and congestive heart failure. Texas Heart Institute journal, 2012, Volume: 39, Issue:5 Topics: Benzazepines; Female; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Infant; Neurophysins; Protein Precursors; Severity of Illness Index; Treatment Outcome; Vasopressins	2012
Effect of the vasopressin receptor antagonist conivaptan in rats with heart failure following myocardial infarction. European journal of pharmacology, 2002, Aug-23, Volume: 450, Issue:2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Male; Myocardial Infarction; Rats; Rats, Wistar; Vasopressins	2002
Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure. European journal of pharmacology, 2005, Jan-10, Volume: 507, Issue:1-3 Topics: Animals; Benzazepines; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Injections, Intravenous; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley	2005
Conivaptan Yamanouchi. Current opinion in investigational drugs (London, England : 2000), 2005, Volume: 6, Issue:3 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Diuretics; Edema; Heart Failure; Humans; Hyponatremia; Molecular Structure; Structure-Activity Relationship; Vasopressins	2005
New drugs for prevention, relief. How you might benefit if 3 medications win FDA approval. Heart advisor, 2005, Volume: 8, Issue:10 Topics: Acetanilides; Angina Pectoris; Benzazepines; Heart Failure; Humans; Obesity; Piperazines; Piperidines; Pyrazoles; Ranolazine; Rimonabant; Tolvaptan	2005
Conivaptan (Vaprisol) for hyponatremia. The Medical letter on drugs and therapeutics, 2006, Jun-19, Volume: 48, Issue:1237 Topics: Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Administration Schedule; Drug Costs; Drug Interactions; Heart Failure; Humans; Hyponatremia; Infusions, Intravenous; Kidney Tubules, Collecting; Randomized Controlled Trials as Topic	2006
Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure. European journal of pharmacology, 1999, Jul-09, Volume: 376, Issue:3 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiac Pacing, Artificial; Cardiovascular Agents; Diuresis; Dogs; Female; Heart Failure; Hemodynamics; Male; Receptors, Vasopressin; Renal Agents	1999
[Pharmacology of conivaptan hydrochloride (YM087), a novel vasopressin V1A/V2 receptor antagonist]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1999, Volume: 114 Suppl 1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Calcium; Cyclic AMP; Dogs; Female; Heart Failure; Humans; Hyponatremia; In Vitro Techniques; Male; Radioligand Assay; Rats; Vasopressins	1999
Vasopressin antagonists in CHF: ready for clinical trials? Cardiovascular research, 2002, Volume: 54, Issue:1 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Heart Failure; Humans	2002
Neurohormonal antagonism in heart failure; beneficial effects of vasopressin V(1a) and V(2) receptor blockade and ACE inhibition. Cardiovascular research, 2002, Volume: 54, Issue:1 Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Captopril; Female; Heart Failure; Myocardium; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Renin	2002